Didier Favre

Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

Jean‐François Viret, Didier Favre, Bernhard Wegmüller et al. · Infection and Immunity · 1999 · 89 citations · Full text

Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.

Guido Dietrich, Simone Spreng, Didier Favre et al. · PubMed · 2003 · 73 citations

Vaccination, Bacterial Vaccines, Mucosal Vaccination +11

IMMUNOGENICITY AND SAFETY OF BERNA-YF COMPARED WITH TWO OTHER 17D YELLOW FEVER VACCINES IN A PHASE 3 CLINICAL TRIAL

Markus Pfister, Oliver Kürsteiner, HELENE HILFIKER et al. · American Journal of Tropical Medicine and Hygiene · 2005 · 50 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +14

Molecular cloning and characterization of the genetic determinants that express the complete <i>Shigella</i> serotype D (<i>Shigella sonnei</i>) lipopolysaccharide in heterologous live attenuated vaccine strains

Jean‐François Viret, Stanley J. Cryz, Aloïs B. Lang et al. · Molecular Microbiology · 1993 · 29 citations

Microbial Pathogens, Immunology, Bacteriology +17

Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae

Didier Favre, Stefan Lüdi, Michael Stoffel et al. · Vaccine · 2006 · 26 citations

Microbial Toxin, Virulence Factor, Vibrio Cholerae +6